Kristin Yarema - 28 Jul 2025 Form 4 Insider Report for ImageneBio, Inc. (IKNA)

Role: Chief Executive Officer, Director
Signature: /s/ Jotin Marango, Attorney-in-Fact
Issuer symbol: IKNA
Transactions as of: 28 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 30 Jul 2025, 21:30:44 UTC
Previous filing: 29 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Yarema Kristin	Chief Executive Officer, Director	C/O IMAGENEBIO, INC., 12526 HIGH BLUFF DRIVE, SUITE 345, SAN DIEGO	/s/ Jotin Marango, Attorney-in-Fact	30 Jul 2025	0001803794

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMA	Employee Stock Option (Right to Buy)	Award	$0	+460,515		$0.000000	460,515	28 Jul 2025	Common Stock	460,515	$16.37	Direct	F1
transaction	IMA	Restricted Stock Units	Award	$0	+153,505		$0.000000	153,505	28 Jul 2025	Common Stock	153,505		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option vests over four years, with 25% of the shares subject to this option vesting on July 25, 2026, and the remaining shares vesting in 36 substantially equal monthly installments thereafter.
F2	Each restricted stock unit (collectively, the "RSUs") represents a contingent right to receive one share of the Issuer's common stock.
F3	The RSUs vest over four years, with 25% of the shares subject to RSUs vesting on the one-year anniversary of the vesting commencement date and the remaining 75% of the shares vesting in equal quarterly installments over the following 12 quarterly dates.